FDA Inspection 1063039 — HomeChoice Partners dba BioScript Infusion Services
The FDA completed an inspection of HomeChoice Partners dba BioScript Infusion Services on August 17, 2018 in Augusta, GA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 17, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Augusta, GA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1435 | 21 CFR 211.42(c)(10)(v) | Cleaning System |
| 3559 | 21 CFR 211.56(a) | Sanitation--buildings not clean, free of infestation |